\t再鼎医药(09688.HK)拟于2月26日审议及发布2025年度业绩

Core Viewpoint - Zai Lab Limited (09688.HK) will present its financial performance for the year ending December 31, 2025, to the board for approval on February 26, 2026, in accordance with US GAAP and SEC regulations [1] Group 1 - The board meeting is scheduled for February 26, 2026, to review and approve the annual financial results [1] - If approved, the annual performance announcement will be published on the Hong Kong Stock Exchange and the company's website on the same day [1]